Home › Trials › NCT05801432
Clinical trial Recruiting at 1 site Observational Ages 19 and up

Evaluating coronary artery disease in patients with diabetes

Official title: Diabetes Follow-up Study for REduction of cardiovAscular outcoMes: a Coronary Computed Tomographic Angiography Cohort Study

Run by Asan Medical Center · NCT05801432 · Data updated 2026-11-12

This study is trying to see how coronary artery disease develops over time in people with diabetes by using special heart scans and gathering health information.

Quick facts

Study typeObservational
Ages19 Years and up
SexAll
Enrollment511 (estimated)
SponsorAsan Medical Center
Academic / other
Locations1 site (Seoul)
StatusRecruiting
StartedAugust 24, 2021
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedMarch 30, 2026
Trial IDNCT05801432 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are asymptomatic patients aged 19 years or older with type 2 diabetes who had an initial CCTA at the Asan Medical Center.

Probably not a fit

Patients with significant renal impairment, a history of severe allergic reactions to contrast media, or those unable to undergo follow-up CCTA may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the natural progression of coronary atherosclerosis in patients with diabetes mellitus using coronary computed tomographic angiography (CCTA). It involves evaluating patients who underwent initial CCTA at the Diabetes Center of the Asan Medical Center from February 2008 to June 2012, with follow-up CCTA based on physician orders. The study will collect demographic data, medical history, cardiovascular risk factors, and laboratory results to identify risk factors associated with coronary atherosclerosis in this population.

Why it matters

Potential benefit: If successful, this study could enhance understanding of coronary artery disease in diabetic patients, leading to better prevention and treatment strategies.

How similar studies have gone: Other studies have shown success in evaluating coronary atherosclerosis in diabetic populations, indicating that this approach is supported by previous research.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Age 19 years or older
* Asymptomatic patients with type 2 DM who had undergone initial CCTA evaluation at the Diabetes Center of the Asan Medical Center between February 2008 and June 2012
* Willing and able to provide informed written consent

Exclusion Criteria:

* Blood test results that the Creatinine level exceeds 1.5 mg/dL
* A person with a history of anaphylaxis or allergic shock associated with a contrast medium
* Pregnant women
* Unable to undergo follow-up CCTA
* Uninterpretable CCTA

Where it's running

  • Asan Medical Center
    Seoul, South Korea     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Diabetes Mellitus 218Asan Medical Center 82
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.